Home / Lifestyle / Health & Fitness / Article /
WHO warns about counterfeit diabetes drugs in circulation worldwide
Updated On: 21 June, 2024 11:19 AM IST | Geneva | IANS
The drug concerns Ozempic, a medicine containing the active ingredient semaglutide, which is also approved in the EU for the treatment of Type 2 diabetes. The counterfeit version looks identical to the real medicine
Listen to this article :
Image for representational purpose only. Photo Courtesy: istock
Counterfeit diabetes drugs have been in circulation since 2022, a problem affecting all regions of the world, the World Health Organization warned in a statement.
The health authority on Thursday referred specifically to findings in Britain, the US and Brazil since October 2023.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT